USPTO serial 97358468
MYCOMEDICA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MARTIN, LIEF ANDREW
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MYCOMEDICA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Emily T. Kappers
Emily T. Kappers CROWELL & MORING LLPP.O. BOX 10395CHICAGO, IL 60610UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Dermatological pharmaceutical products; Pharmaceutical skin lotions; Digestives for pharmaceutical purposes; Pharmaceutical preparations for skin care; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical products for the treatment and prevention of psychiatric and neurological disease; Nutraceuticals for use as a dietary supplement; Nutraceuticals for the treatment and prevention of psychiatric and neurological disease; Dietary supplements; Dietary and nutritional supplements; Therapeutic pharmaceutical for the treatment of psychiatric and neurological disease; Therapeutic pharmaceutical for the treatment of mental health disorders; Extracts from plants for pharmaceutical purposes; Herbal extracts for pharmaceutical purposes; Mushroom extracts for pharmaceutical purposes; Fungal extracts for pharmaceutical purposes; Fungal extracts sold as a component ingredient of nutritional supplements and vitamins; Topical anesthetics; Topical analgesics; Topical analgesic creams; Topical gel for medical and therapeutic treatments, namely, for dermatological use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 20, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 19, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 24, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 22, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 22, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 22, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 17, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 22, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 22, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 2, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 14, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 14, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 14, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 14, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 14, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 11, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 19, 2022 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Apr 18, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 15, 2022 | NWAP | NEW APPLICATION ENTERED | — |